Linda Ponce
Critical Care Medicine · Houston, TXNPI 1972296408
Payments from drug & device makers
Across 65 payments — averaging $22.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- United Therapeutics Corporation$280
- Actelion Pharmaceuticals US, Inc.$226
- Takeda Pharmaceuticals U.S.A., Inc.$167
- Regeneron Healthcare Solutions, Inc.$137
- Baxter Healthcare$136
- AbbVie$129
- plus $395 from 9 others
What the payments were for
- Food & beverage$1,470100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| United Therapeutics Corporation | 14 | $280 |
| Actelion Pharmaceuticals US, Inc. | 8 | $226 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $167 |
| Regeneron Healthcare Solutions, Inc. | 5 | $137 |
| Baxter Healthcare | 6 | $136 |
| AbbVie | 8 | $129 |
| Grifols USA, LLC | 5 | $123 |
| Shionogi Inc | 3 | $78 |
| Astellas Pharma US Inc | 2 | $54 |
| Bayer | 2 | $35 |
| Merck | 1 | $24 |
| Mallinckrodt Hospital Products Inc. | 1 | $22 |
| Sanofi | 1 | $21 |
| Alcresta Therapeutics, Inc. | 1 | $21 |
| AstraZeneca | 1 | $17 |
How this compares
$1,470 in reported general payments places this provider in the 65th percentile of 507 critical care medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other critical care medicine in Houston
- Deepa GoturHouston$1.1M
- Matt KhoshnevisHouston$759K
- Rodeo AbrencilloHouston$616K
- Bindu AkkantiHouston$288K
- Edwin ParsleyHouston$283K
- Daniela MoranHouston$276K
- Faisal MasudHouston$219K
- George WilliamsHouston$188K
- Sergio Trevino CastilloHouston$133K
- Prangthip CharoenpongHouston$67K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.